Mannheim Holdings
3
5M
2
0.33
1
- Stages of investment
- Areas of investment
Summary
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Mannheim Holdings, startups are often financed by Swissfirst Bank AG, Heidelberg Innovation, HBM Healthcare Investments AG. The meaningful sponsors for the fund in investment in the same round are Heidelberg Innovation, HBM Healthcare Investments AG, Swissfirst Bank AG. In the next rounds fund is usually obtained by HBM Healthcare Investments AG, Swissfirst Bank AG, Wellington Partners.
Opposing the other organizations, this Mannheim Holdings works on 4 percentage points more the average amount of lead investments. The common things for fund are deals in the range of 5 - 10 millions dollars. The top amount of exits for fund were in 2011. The fund is generally included in less than 2 deals every year. The important activity for fund was in 2002.
Among the most popular portfolio startups of the fund, we may highlight Pelikan Technologies, MTM Laboratories. Among the most popular fund investment industries, there are Health Diagnostics, Biotechnology. Besides, a startup needs to be aged 2-3 years to get the investment from the fund.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Exits
- 1
- Follow on index
- 0.33
- Investments by industry
- Biotechnology (3)
- Medical Device (2)
- Health Care (2)
- Health Diagnostics (1)
- Medical (1)
- Investments by region
-
- United States (2)
- Germany (1)
- Peak activity year
- 2006
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 21
- Avg. valuation at time of investment
- 76M
- Group Appearance index
- 1.00
- Avg. company exit year
- 12
- Avg. multiplicator
- 1.56
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| MTM Laboratories | 30 Aug 1999 | Biotechnology, Health Diagnostics, Medical | Early Stage Venture | 1M | Germany, Baden-Württemberg, Heidelberg |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.